Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.

Roque-Cuéllar MC, Sánchez B, García-Lozano JR, Praena-Fernández JM, Núñez-Roldán A, Aguilar-Reina J.

J Viral Hepat. 2011 Oct;18(10):e541-9. doi: 10.1111/j.1365-2893.2011.01464.x.

PMID:
21914075
2.

Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.

Roque-Cuéllar MC, Sánchez B, García-Lozano JR, Praena-Fernández JM, Márquez-Galán JL, Núñez-Roldán A, Aguilar-Reina J.

Liver Int. 2014 Jul;34(6):e80-8. doi: 10.1111/liv.12320. Epub 2013 Oct 16.

PMID:
24127783
3.

Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.

Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, Bouwer HG, Hinrichs DJ.

Hepatology. 2002 Jan;35(1):190-8.

PMID:
11786976
4.

Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?

Lee S, Hammond T, Watson MW, Flexman JP, Cheng W, Fernandez S, Price P.

Clin Exp Immunol. 2010 Jul 1;161(1):118-26. doi: 10.1111/j.1365-2249.2010.04141.x. Epub 2010 Apr 9.

5.

Cellular immune responses associated with occult hepatitis C virus infection of the liver.

Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, Pardo M, Carreño V.

J Virol. 2006 Nov;80(22):10972-9.

6.

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.

Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H, Rehermann B.

J Immunol. 2002 Sep 15;169(6):3447-58.

8.

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV.

Gastroenterology. 2000 Feb;118(2):346-55.

PMID:
10648463
9.

Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

Hashem M, El-Karaksy H, Shata MT, Sobhy M, Helmy H, El-Naghi S, Galal G, Ali ZZ, Esmat G, Abdelwahab SF, Strickland GT, El-Kamary SS.

J Infect Dis. 2011 Mar 15;203(6):854-61. doi: 10.1093/infdis/jiq123. Epub 2011 Jan 21.

10.
11.

Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.

Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Carreño V.

J Med Virol. 2006 Sep;78(9):1190-7.

PMID:
16847959
12.

Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response.

Sugimoto K, Stadanlick J, Ikeda F, Brensinger C, Furth EE, Alter HJ, Chang KM.

Hepatology. 2003 Mar;37(3):590-9.

PMID:
12601357
13.

Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.

Kawakami Y, Nabeshima S, Furusyo N, Sawayama Y, Hayashi J, Kashiwagi S.

Am J Gastroenterol. 2000 Jan;95(1):227-32.

PMID:
10638589
14.

Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses.

Pillai V, Lee WM, Thiele DL, Karandikar NJ.

J Viral Hepat. 2007 May;14(5):318-29.

PMID:
17439521
15.

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.

Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ, Chisari FV.

Hepatology. 2001 Jan;33(1):267-76.

PMID:
11124845
16.

HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.

Rallón NI, Soriano V, Restrepo C, García-Samaniego J, Labarga P, López M, Peris A, González-Lahoz J, Benito JM.

J Acquir Immune Defic Syndr. 2011 May 1;57(1):1-8.

PMID:
21786458
17.

Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.

Semmo N, Krashias G, Willberg C, Klenerman P.

J Viral Hepat. 2007 Jul;14(7):492-502.

PMID:
17576391
18.

The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome.

Löhr HF, Gerken G, Roth M, Weyer S, Schlaak JF, Meyer zum Büschenfelde KH.

J Hepatol. 1998 Oct;29(4):524-32.

PMID:
9824260
19.

Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.

Brady MT, MacDonald AJ, Rowan AG, Mills KH.

Eur J Immunol. 2003 Dec;33(12):3448-57.

20.

Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection.

Lancaster T, Sanders E, Christie JM, Brooks C, Green S, Rosenberg WM.

J Viral Hepat. 2002 Jan;9(1):18-28.

PMID:
11851899
Items per page

Supplemental Content

Write to the Help Desk